SoPE-GW Webinar: Understanding the BIOSECURE Act

May 30, 2024

Noon Eastern Time

Register to Attend

We invite you to a webinar on the BIOSECURE Act, hosted in collaboration with the Society of Physician Entrepreneurs (SoPE) and the George Washington University Technology Commercialization Office (TCO).

This session will delve into bills in Congress focusing on collaboration constraints for the biotechnology sector with entities from certain foreign nations. Biotech companies of all sizes should prepare for the potential impacts of this legislation.

Topics:

1. What is the BIOSECURE Act? How could it impact U.S. biotech companies? The bill aims to keep taxpayer dollars out of the hands of so-called “foreign adversary biotech companies of U.S. national security concern.”

2. How to be prepared. If no more business is allowed with the blocked companies like Wuxi, what are the alternatives?

Speakers:

Dr. Qing Zhang, from LDV Partners, is an experienced venture capital professional in Biotech and HealthTech, and a trained physician.

Lindsey M. Nelson, partner at Jones Day, specializes in compliance with international trade and government contract laws.

Moderator:

Dr. Jeffrey Hausfeld, Chairman of BioFactura and Co-Founder of SoPE, is renowned for his leadership in biotechnology investments and healthcare innovation. His extensive experience in biotech and medical startups provides invaluable insights into navigating regulatory and investment challenges.

For more information email us at [email protected].